Combining mental health coaching with medication optimization significantly reduces anxiety and depression in older adults recovering from major surgery, according to a clinical trial published September 9 in JAMA Network Open. Led by researchers at Washington University School of Medicine in St. Louis, the trial demonstrates that preparing the mind for invasive procedures is just as critical as physical conditioning.
Addressing Perioperative Psychological Distress
Traditional perioperative care focuses almost exclusively on physical healing, frequently leaving emotional distress untreated. According to Dr. Eric J. “We recognize the importance of getting the body into shape before surgery, but preparing the mind and the brain is just as important,” Lenze said, noting that emotional well-being and medication management help deliver better post-surgical outcomes.
Structure of the Clinical Trial and Intervention
The trial evaluated 306 adults aged 60 and older scheduled for cardiac, oncologic, or orthopedic procedures across the BJC HealthCare system. Participants reporting mild to moderate symptoms of depression and anxiety were randomly assigned to either an intervention group or a control group. According to the study, patients in the intervention group received educational materials on mindfulness, sleep, and brain health alongside eight to 12 phone sessions with a dedicated wellness coach, such as a social worker or mental health counselor. Pharmacists and physicians also provided a personalized medication review to safely optimize doses of high-risk drugs.
Older patients frequently take multiple medications affecting the brain—including sedatives, muscle relaxants, and over-the-counter sleep aids. Without routine re-evaluations, these prescriptions accumulate, raising the risk of confusion, dangerous falls, and long-term physical pain after an operation. The control group received standard educational materials only.
Bridging Anesthesiology and Psychiatry
The trial was conducted through WashU Medicine’s Center for Perioperative Mental Health, which aims to integrate holistic mental health care into routine surgical medicine. Joanna Abraham, PhD, a professor in the Department of Anesthesiology at WashU Medicine and first author of the study, emphasized the timing of the intervention. “The time around surgery is a window of both risk and opportunity,” Abraham said, explaining that the stress of surgery worsens symptoms but also creates a critical opening to connect patients with necessary support. Michael S. Avidan, MBBCh, of WashU Medicine, added that the findings offer a practical blueprint for hospital systems nationwide to combine anesthesiology and psychiatry for more holistic patient care.
Keep reading
- ARO-RAGE: New Inhaled RNA Therapy for Asthma and COPD Inflammation
- Lisbon Ambulance Crew Assists in Imminent Childbirth
- Shift Supervisor Job at CVS Health – Bristol, Rhode Island (news-usa.today)
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)